MLchartDataset catalogue

Patent · US6089227A · A · US

Device for an inhaler

(11) Publication number
US6089227A
(21) Application number
US-99609797-A
(22) Filing date
1997-12-22
(30) Priority date
1995-06-21
(43) Publication date
2000-07-18
(45) Date of grant
2000-07-18
(52) CPC
  • A61M Devices for introducing media into, or onto, the body; devices for transducing body media or for taking media from the body; devices for producing or ending sleep or stupor {}: 15/02, 15/00, 15/0065, 2202/064
(73) Assignee
MICRODRUG AG
(54) Title
Device for an inhaler
(57) Abstract

An inhaler for electrical dosing of pure substances or preparates consisting of chemical and biological substances mainly used as drugs. The inhaler, which comprises a microprocessor thereby offers a flexible and measurable dose for the chemical and biological substances in the form of powders, or in the form of small drops or aerosols. The dosing is done electrically via first field generating member (23) whereby the substance is transmitted to a transmitting member which attracts the substance, from which the substance is then emitted by influence from another electrical field generated by a second field generating member (32), and the substance is finally mixed with air which is conventionally inhaled.

Full text
View on Google Patents

Claims (10)

  1. A device for an inhaler, comprising a power source for the creation of suitable electric potentials for the administration of substances, wherein dosing is achieved by an electrostatic charging of the substance via a first field generating member (23), the substance being transmitted to a transmission member, which attracts said substance, from which transmission member the substance is emitted by the influence of an additional electric field generated by a second field generating member (32), the transmission member comprising a dosing drum (24), which during rotation by a built-in motor (26) will emit the substance by the influence from the additional electric field generated by the second field generating member (32).
  2. The device according to claim 1, wherein the substance is emitted from a dosing drum (24) in the device by a combination of the additional electric field and an air stream resulting from inspiration.
  3. The device according to claim 1, wherein the inhaler is additionally inspiration controlled, whereby no substance is emitted from the dosing drum (24) until an air stream has been detected by means of an air flow gauge (15).
  4. The device according to claim 1, wherein the inhaler is furthermore provided with an accelerator member (29), a deionizing member (30) and a diffusor member (16), which are included in a nozzle member.
  5. The device according to claim 1, wherein the inhaler is provided with a micro processor (42) which can be programmed for the control of dosing, flows, time, number of doses, limits, and security codes, which furthermore enables an advanced follow up of the patient usage of the substance or substances during a period of time signaling overdosing, faulty usage or trends.
  6. The device according to claim 1, wherein the inhaler is provided with a function indicator (43) which warns in the case of risk for overdosing or faulty usage and also gives clearance in case of a dose correctly emitted and received by the patient.
  7. The device according to claim 1, wherein the substance is electrostatically charged by tribocharging or inductive charging to a potential.
  8. The device according to claim 1, wherein the inhaler is coupled with the person performing the inspiration thereby decreasing the risk of substance depositing in the mouth and in the upper airways.
  9. The device according to claim 1, wherein the substances which are dosed are thus prepared that their electrical characteristics are suited for the electric dosing.
  10. The device according to claim 1, wherein the substance is a powder and the electrical characteristics of the powder are optimized by the addition of carriers, or by surface treatment of the powder, and wherein a correct particle size and particle structure is used.

Citations (13)

  • US4788016A
  • US4829996A
  • US5033463A
  • US5267555A
  • US5497764A
  • US5642727A
  • US5857456A
  • US5875776A
  • US5915377A
  • WO9209322A1
  • WO9215353A2
  • WO9414543A2
  • WO9419042A1
Record as JSON
{
  "publication_number": "US6089227A",
  "country": "US",
  "kind": "A",
  "title": "Device for an inhaler",
  "abstract": "An inhaler for electrical dosing of pure substances or preparates consisting of chemical and biological substances mainly used as drugs. The inhaler, which comprises a microprocessor thereby offers a flexible and measurable dose for the chemical and biological substances in the form of powders, or in the form of small drops or aerosols. The dosing is done electrically via first field generating member (23) whereby the substance is transmitted to a transmitting member which attracts the substance, from which the substance is then emitted by influence from another electrical field generated by a second field generating member (32), and the substance is finally mixed with air which is conventionally inhaled.",
  "claims": [
    "1. A device for an inhaler, comprising a power source for the creation of suitable electric potentials for the administration of substances, wherein dosing is achieved by an electrostatic charging of the substance via a first field generating member (23), the substance being transmitted to a transmission member, which attracts said substance, from which transmission member the substance is emitted by the influence of an additional electric field generated by a second field generating member (32), the transmission member comprising a dosing drum (24), which during rotation by a built-in motor (26) will emit the substance by the influence from the additional electric field generated by the second field generating member (32).",
    "2. The device according to claim 1, wherein the substance is emitted from a dosing drum (24) in the device by a combination of the additional electric field and an air stream resulting from inspiration.",
    "3. The device according to claim 1, wherein the inhaler is additionally inspiration controlled, whereby no substance is emitted from the dosing drum (24) until an air stream has been detected by means of an air flow gauge (15).",
    "4. The device according to claim 1, wherein the inhaler is furthermore provided with an accelerator member (29), a deionizing member (30) and a diffusor member (16), which are included in a nozzle member.",
    "5. The device according to claim 1, wherein the inhaler is provided with a micro processor (42) which can be programmed for the control of dosing, flows, time, number of doses, limits, and security codes, which furthermore enables an advanced follow up of the patient usage of the substance or substances during a period of time signaling overdosing, faulty usage or trends.",
    "6. The device according to claim 1, wherein the inhaler is provided with a function indicator (43) which warns in the case of risk for overdosing or faulty usage and also gives clearance in case of a dose correctly emitted and received by the patient.",
    "7. The device according to claim 1, wherein the substance is electrostatically charged by tribocharging or inductive charging to a potential.",
    "8. The device according to claim 1, wherein the inhaler is coupled with the person performing the inspiration thereby decreasing the risk of substance depositing in the mouth and in the upper airways.",
    "9. The device according to claim 1, wherein the substances which are dosed are thus prepared that their electrical characteristics are suited for the electric dosing.",
    "10. The device according to claim 1, wherein the substance is a powder and the electrical characteristics of the powder are optimized by the addition of carriers, or by surface treatment of the powder, and wherein a correct particle size and particle structure is used."
  ],
  "cpc": [
    "A61M 15/02",
    "A61M 15/00",
    "A61M 15/0065",
    "A61M 2202/064"
  ],
  "assignees": [
    "MICRODRUG AG"
  ],
  "filing_date": "1997-12-22",
  "publication_date": "2000-07-18",
  "grant_date": "2000-07-18",
  "priority_date": "1995-06-21",
  "application_number": "US-99609797-A",
  "family_id": "20398701",
  "citations": [
    "US4788016A",
    "US4829996A",
    "US5033463A",
    "US5267555A",
    "US5497764A",
    "US5642727A",
    "US5857456A",
    "US5875776A",
    "US5915377A",
    "WO9209322A1",
    "WO9215353A2",
    "WO9414543A2",
    "WO9419042A1"
  ]
}

Record 3,553 of 5,000 in Patents full text (MLC-0201). Request the full dataset.